Infection with Epstein-Barr virus (EBV) results in the development of virus-specific antibodies. The pattern of these antibodies helps to stage the illness . EBV-VCA (IgG) Ab
**Core Concept**
The development of virus-specific antibodies, particularly IgG against Epstein-Barr virus capsid antigen (EBV-VCA), is a crucial marker for diagnosing and staging infectious mononucleosis (IM), also known as glandular fever. This antibody response indicates a past or current EBV infection.
**Why the Correct Answer is Right**
The presence of IgG antibodies against EBV-VCA signifies a recent or chronic EBV infection. These antibodies are produced in response to the viral capsid antigen, which is a protein component of the EBV virus. IgG antibodies indicate a more sustained immune response compared to IgM, which is typically seen in the acute phase of the infection. The pattern of EBV-VCA IgG antibodies helps clinicians differentiate between acute, convalescent, and chronic phases of the illness.
**Why Each Wrong Option is Incorrect**
* **Option A:** Incorrect because IgM antibodies against EBV-VCA are typically seen in the acute phase of the infection, not the convalescent phase.
* **Option B:** Incorrect because IgG antibodies against EBV-EA (early antigen) are typically seen in the acute phase of the infection, not the convalescent phase.
* **Option C:** Incorrect because IgG antibodies against EBV-EBNA (Epstein-Barr nuclear antigen) are typically seen in the convalescent phase of the infection, not the acute phase.
**Clinical Pearl / High-Yield Fact**
The presence of IgG antibodies against EBV-VCA can be seen in both acute and convalescent phases of the illness, making it a useful marker for diagnosing and staging infectious mononucleosis. However, the absence of these antibodies in a patient with symptoms of IM does not rule out the diagnosis, as some patients may not develop detectable levels of these antibodies.
**Correct Answer:** D.